{"id":50008,"date":"2026-06-04T07:59:53","date_gmt":"2026-06-04T11:59:53","guid":{"rendered":"https:\/\/www.iff.com\/?post_type=team&p=50008"},"modified":"2026-06-04T07:59:55","modified_gmt":"2026-06-04T11:59:55","slug":"simon-bird","status":"publish","type":"team","link":"https:\/\/www.iff.com\/es\/experts\/simon-bird\/","title":{"rendered":"Simon Bird"},"content":{"rendered":"
\n\n\t\n\t\n\t
\n\n\t\t
\n\n\t\t\t\n
\n\t
\n\t\t
\n\t\t\t
\n\n\t\t\t\t\n\t\t\t\t
\n\t\t\n\t\t\n\t\t\t\t\t

Career Background <\/h2>\t\t\n\t\t\n\t\t <\/div>\n\t
\n\t\t\t\t\t

Bird built his career over more than 12 years across the Chemical and Biotech sectors. He began as a production engineer in the UK specialty chemical industry, with a focus on process\u00a0optimisation, before moving into commercial roles across Europe with Dow Chemical and DuPont. Originally from the Channel Islands, he has long been motivated by a passion for resource conservation and simplicity.<\/p>\n

This interest led him to take on the Regional Lead role for Europe & Middle East within IFF\u2019s Food Enzymes business, before being appointed to the Global Business Director role in 2023. He has since been promoted to his current position as VP, Food & Beverage Biosciences \u2014 a role that reflects IFF\u2019s broader strategic consolidation of its\u00a0biosciences\u00a0capabilities.<\/p>\n

His background in legacy DuPont and Danisco enzyme businesses gives him rare institutional depth: IFF\u2019s food enzyme portfolio has its roots in Danisco\/DuPont Nutrition & Biosciences, which IFF\u00a0acquired\u00a0in a landmark\u00a0$26 billion\u00a0merger in 2021. Bird is one of the leaders who carried that heritage forward.<\/p>\n

Bird is a commercially astute, technically grounded leader who has helped reframe food enzymes from a niche processing aid into a strategic pillar of sustainable food manufacturing. His progression from production engineer to global VP at one of the world\u2019s largest ingredient companies reflects a blend of scientific credibility, commercial acumen, and a clear sustainability-driven narrative. He is well-positioned as a thought leader for audiences in bakery, food ingredients, clean label strategy, and bioscience-led food innovation.<\/p>\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/div>\n\n\t \n\t\t\t<\/div>\n\n \n\t\t\t\t\t<\/div>\n\t<\/div>\n\n\t

\n\t\t\t
\n\n\t\t\t\t\t
\n\t\t\t\t\"image\t\t\t<\/div>\n\t\t\n\t\t\n\t<\/div>\n\t\n\t\t\t<\/div>\n<\/div>\n\n\t\t<\/div>\n\n\t<\/div>\n\n\t\n<\/div>\n\n\n
\n\n\t\n\t\n\t
\n\n\t\t
\n\n\t\t\t\n
\n\t
\n\t\t
\n\t\t\t
\n\n\t\t\t\t\n\t\t\t\t
\n\t\t\n\t\t\n\t\t\t\t\t

Strategic Context & Industry Positioning <\/h2>\t\t\n\t\t\n\t\t <\/div>\n\t
\n\t\t\t\t\t

Bird has been candid about the evolving commercial landscape: with IFF\u2019s strategic review of its Food Ingredients business underway, he has positioned the food enzymes portfolio as firmly core to IFF\u2019s future within the Health & Biosciences division. This is a meaningful signal \u2014 he is effectively steering a business through a period of corporate portfolio reconfiguration while\u00a0maintaining\u00a0commercial momentum.<\/p>\n

Looking ahead, he\u00a0identifies\u00a0five key forces reshaping the bakery sector:<\/p>\n